Bumper Offer - Urjas oil Just @ Rs. 1 X
Telmisat 40 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Heart Failure, High BP. Other than this, Telmisat 40 Tablet has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Telmisat 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Telmisat 40 Tablet include Dizziness, Nausea or vomiting, Back Pain. Apart from the aforementioned side effects, Telmisat 40 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Telmisat 40 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Telmisat 40 Tablet's effect during pregnancy is Severe and Mild while nursing. In addition, Telmisat 40 Tablet's effects on the liver, heart and kidney are discussed below in the Telmisat 40 Tablet related warnings section.
Individuals suffering from medical conditions like Angioedema, Hyperkalemia, Drug Allergy must refrain from the use of Telmisat 40 Tablet since this can cause severe adverse effects.
Drug interactions for Telmisat 40 Tablet have been reported in the medical literature. See below for a complete list.
In addition to these precautions, you may also note that Telmisat 40 Tablet is not safe while driving, and is is not addictive in nature.
Telmisat 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Telmisat 40 Tablet is used -
Severe
Mild
Common
Is the use of Telmisat 40 Tablet safe for pregnant women?
Telmisat can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Telmisat 40 Tablet safe during breastfeeding?
Side effects of Telmisat for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Telmisat 40 Tablet on the Kidneys?
Telmisat is completely safe for kidneys.
What is the effect of Telmisat 40 Tablet on the Liver?
Telmisat has very mild side effects on the liver.
What is the effect of Telmisat 40 Tablet on the Heart?
Side effects of Telmisat rarely affect the heart.
Telmisat 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Telmisat 40 Tablet unless your doctor advises you to do so -
Is this Telmisat 40 Tablet habit forming or addictive?
No, there is no any evidence that Telmisat 40 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Telmisat 40 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Telmisat 40 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Telmisat 40 Tablet in mental disorders is not effective.
Interaction between Food and Telmisat 40 Tablet
Some foods when eaten with Telmisat 40 Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Telmisat 40 Tablet
Taking Telmisat 40 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Micardis® (telmisartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Twynsta® (telmisartan/amlodipine)